Boehringer Ingelheim develops potential treatment for severe COVID-19 complications
The FINANCIAL -- Boehringer Ingelheim announced the initiation of a Phase 2 clinical trial of BI 764198, an inhibitor of ...
ADVERTISEMENT
Tag: COVID-19 Therapeutics Accelerator
ADVERTISEMENT
Popular Last 24h
-
Ampersand wins £22m five-year contract at London Zoo
-
Who Is the Owner of QI Company? A Look at the QI Group’s Leadership Shaping Its Future
-
Patricia White Appointed as a Class C Director to the New York Fed Board of Directors
-
Biden Job Approval Second Lowest Among Post-WWII Presidents
-
The great global redistributor we never hear about: money sent or brought back by migrants
-
The pharmaceutical industry, grappling with new government limits on drug prices
-
ICE Acquires the American Financial Exchange (AFX)
LATEST POSTS
LATESTINTERVIEWS
ADVERTISEMENT
